Latest Everolimus Stories
A new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus.
The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumor cells.
Four proteins involved in translation, the final step of general protein production, are associated with poor prognosis in hormone-receptor-positive breast cancer when they are dysregulated.
Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chances of cancer spreading (metastasising) in the bone.
- Withering but not falling off, as a blossom that persists on a twig after flowering.